First-in-Human Study of TAK-280 in Participants With Solid Tumors

Clinical trial NCT05220098 · TERMINATED

Trial details

NCT number: NCT05220098
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Unresectable Locally Advanced or Metastatic Cancer

Start date: 2022-04-21
Primary completion: 2025-07-28
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.